{"id":"NCT02291549","sponsor":"Intersect ENT","briefTitle":"S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Nasal Polyps","officialTitle":"A Clinical Evaluation of the Safety and Efficacy of the Steroid-Releasing S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Sinus Obstruction","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-12","primaryCompletion":"2016-10","completion":"2016-10","firstPosted":"2014-11-14","resultsPosted":"2018-07-09","lastUpdate":"2018-08-15"},"enrollment":300,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Sinusitis","Nasal Polyposis"],"interventions":[{"type":"DRUG","name":"S8 Sinus Implant","otherNames":["SINUVA (mometasone furoate) sinus implant"]},{"type":"DRUG","name":"Mometasone furoate nasal spray","otherNames":["Nasonex"]},{"type":"PROCEDURE","name":"Sham","otherNames":["Sham procedure"]}],"arms":[{"label":"Treatment","type":"EXPERIMENTAL"},{"label":"Control","type":"SHAM_COMPARATOR"}],"summary":"The RESOLVE II Study is a randomized, single-blind, parallel arm, concurrently controlled, multicenter study with 300 chronic sinusitis patients who had prior endoscopic sinus surgery but present with recurrent sinus obstruction.","primaryOutcome":{"measure":"Nasal Obstruction/Congestion Score","timeFrame":"Day 30","effectByArm":[{"arm":"Treatment","deltaMin":2.36,"sd":0.488},{"arm":"Control","deltaMin":2.35,"sd":0.479}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0074"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":16},"locations":{"siteCount":40,"countries":["United States"]},"refs":{"pmids":["29350840"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":201},"commonTop":["Acute Sinusitis","Chronic Sinusitis","Upper respiratory tract infection","Asthma"]}}